AT13148
| CAS号 | 1056901-62-2 | 货号 | BCP08961 |
| 中文名 | AT13148 | ||
| 英文名 | AT13148 | ||
| 中文别名 | |||
| 英文别名 | AT 13148; AT-13148; | ||
| 分子式 | C17H16ClN3O | 分子量 | 313.78 |
| 生物活性 | AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors. AT13148 is currently being developed by Astex Pharmaceuticals. AT131148 was identified utilizing high-throughput X-ray crystallography and fragment-based lead discovery techniques. AT13148 caused substantial blockade of AKT, p70S6K, PKA, ROCK and SGK substrate phosphorylation and induction of apoptosis in both a concentration and time-dependent manner in cancer cells with clinically relevant genetic defects both in vitro and in vivo. | ||
| 信号通路 | Cell Cycle/DNA Damage GPCR/G Protein TGF beta/Smad Wnt/Stem Cell PI3K/Akt/mTOR MAPK Pathway | ||
| 靶 点 | ROCK PKA RSK AKT | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！